AzTrials
AzTrials

Peri-implant MucositisNCT06901388

Peri-implant Disease Perception Before and After Non-Surgical Peri-implant Therapy

A study testing Non-surgical peri-implant therapy in people with Peri-implant Mucositis and Peri-Implantitis, run by University of Siena at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present pre-post quasi-experimental study assessed changes in peri-implant disease perception and oral health-related quality of life following non-surgical peri-implant therapy. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Peri-implant Mucositis, Peri-Implantitis
What is being tested?
Non-surgical peri-implant therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteItaly
Study dates
31 Mar 2025to 29 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 to 80 years
  • Diagnosis of peri-implant disease requiring non-surgical therapy
  • Presence of at least one dental implant loaded for a minimum of one year
  • History of periodontitis
  • Good general health
  • Ability to provide written informed consen

Who cannot join

  • Pregnant or lactating individuals
  • Inability to perform basic oral hygiene procedures
  • Inability to understand or complete study questionnaires

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • AOUS

    Siena, 53100

Other trials in Italy

About this study

Official title: Peri-implant Disease Perception Before and After Non-Surgical Peri-implant Therapy: A Pre-post Quasi-Experimental Study

The present pre-post quasi-experimental study assessed changes in peri-implant disease perception and oral health-related quality of life following non-surgical peri-implant therapy. Using validated psychometric tools, including the Brief Illness Perception Questionnaire (Brief-IPQ) and the Oral Health Impact Profile-14 (OHIP-14), the study evaluates patients at baseline and three months after therapy. The study builds upon prior cross-sectional findings highlighting the low perception of peri-implant diseases and aims to determine whether non-surgical treatment improves patients' psychological awareness and perceived impact of their condition.

Being tested
Non-surgical peri-implant therapy
Keywords
Oral Health Impact Profile 14, Brief-Illness Perception Questionnaire, Non-surgical peri-implant therapy
Medical subject headings
Peri-Implantitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-surgical peri-implant therapyProcedure or surgery

    Also called Mechanical debridement + Oral hygiene instruction

    Standardized non-surgical therapy consisting of mechanical debridement of peri-implant sites using ultrasonic instruments, combined with personalized oral hygiene instruction. The intervention is delivered in a single session. No adjunctive antimicrobials are used. Follow-up is scheduled 3 months after therapy for clinical and psychometric re-evaluation.

Study groups in NCT06901388
Study groupRoleWhat they receive
Single groupExperimentalAll participants will receive non-surgical peri-implant therapy consisting of mechanical debridement and oral hygiene instruction. Psychometric assessments (Brief-IPQ and OHIP-14) will be administered at baseline and 3 months after treatment to evaluate changes in illness perception and oral health-related quality of life.
Receives: Procedure: Non-surgical peri-implant therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in illness perception (Brief-IPQ total score)

    Illness perception will be assessed using the Brief Illness Perception Questionnaire (Brief-IPQ). The primary outcome is the change in the total score from baseline to 3 months after baseline, following non-surgical peri-implant therapy.

    Measured: Baseline and 3 months from baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2025
  2. Study start31 Mar 2025
  3. Primary completion29 Jul 2025
  4. Study completion29 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06901388
Sponsor's protocol ID
BIPP001
Status last verified
Jul 2025
First submitted
22 Mar 2025
Last updated
30 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Non-surgical peri-implant therapy in people with Peri-implant Mucositis and Peri-Implantitis, run by University of Siena at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in illness perception (Brief-IPQ total score) (time frame: Baseline and 3 months from baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in